According to The Guardian, a growing stream of Black American women is traveling to Seoul for preventive screenings, diagnostics, dermatology, and comprehensive workups. Patients report that South Korean clinics offer lower costs and shorter wait times. They also describe a level of clinical attention and follow-up they struggle to access in US hospitals and private practices.
At its core, this is a trust story. When patients are willing to cross an ocean for basic screening and thorough examination, the problem runs deeper than price or scheduling. It signals a belief that the US medical system will miss something critical, and that oversight will land hardest on Black women—a population with well-documented disparities in diagnosis, treatment, and outcomes.
Whether this remains a niche option for patients with passports and savings, or evolves into a broader medical travel industry targeting underserved Americans, will become clear in the next few years. The harder test: whether US hospitals, insurers, and regulators treat this as a warning about clinical outcomes or dismiss it as a branding problem.
Medical tourism usually signals a hunt for bargains. This signals an indictment. If patients believe they need to leave the country to be listened to, examined properly, and told what is happening inside their own bodies, American healthcare has moved past inconvenience into a legitimacy crisis. Plane tickets are expensive. Being dismissed is pricier.
Filed to the World desk · Jul 18